Loading...
Cibus, Inc.
CBUS•NASDAQ
HealthcareBiotechnology
$1.66
$0.11(7.10%)
Cibus, Inc. (CBUS) Financial Performance & Statements
Review Cibus, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
134.56%
↑ 134.56%
Operating Income Growth
18.97%
↑ 18.97%
Net Income Growth
6.07%
↑ 6.07%
Operating Cash Flow Growth
-25.61%
↓ 25.61%
Operating Margin
-5925.36%
↓ 5925.36%
Gross Margin
63.52%
↑ 63.52%
Net Profit Margin
-5784.87%
↓ 5784.87%
ROE
-203.18%
↓ 203.18%
ROIC
-89.65%
↓ 89.65%
Cibus, Inc. (CBUS) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Cibus, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.21M | $1.67M | $838000.00 | $545000.00 |
| Cost of Revenue | $0.00 | $0.00 | $1.73M | $1.77M |
| Gross Profit | $1.21M | $1.67M | -$895000.00 | -$1.22M |
| Gross Profit Ratio | $1.00 | $1.00 | -$1.07 | -$2.24 |
| R&D Expenses | $12.43M | $12.99M | $12.99M | $12.01M |
| SG&A Expenses | $6.80M | $7.68M | $7.59M | $6.99M |
| Operating Expenses | $19.24M | $202.10M | $20.59M | $19.00M |
| Total Costs & Expenses | $19.24M | $202.10M | $22.32M | $19.00M |
| Interest Income | $109000.00 | $160000.00 | $169000.00 | $193000.00 |
| Interest Expense | $8.24M | $8.88M | $8.75M | $8.33M |
| Depreciation & Amortization | $1.65M | $1.66M | $1.73M | $1.77M |
| EBITDA | -$15.91M | -$190.91M | -$18.00M | -$16.86M |
| EBITDA Ratio | -$13.13 | -$114.53 | -$21.48 | -$30.94 |
| Operating Income | -$18.02M | -$200.44M | -$21.48M | -$18.45M |
| Operating Income Ratio | -$14.87 | -$120.24 | -$25.63 | -$33.86 |
| Other Income/Expenses (Net) | -$7.77M | -$1.009M | -$7.00M | -$8.51M |
| Income Before Tax | -$25.80M | -$201.45M | -$28.48M | -$26.96M |
| Income Before Tax Ratio | -$21.29 | -$120.84 | -$33.99 | -$49.46 |
| Income Tax Expense | $6000.00 | $13000.00 | -$4000.00 | -$14000.00 |
| Net Income | -$23.10M | -$179.97M | -$24.88M | -$23.43M |
| Net Income Ratio | -$19.06 | -$107.96 | -$29.69 | -$43.00 |
| EPS | -$0.87 | -$7.63 | -$1.14 | -$1.12 |
| Diluted EPS | -$0.87 | -$7.63 | -$1.14 | -$1.12 |
| Weighted Avg Shares Outstanding | $26.55B | $23.59B | $21.85B | $20.86B |
| Weighted Avg Shares Outstanding (Diluted) | $26.55B | $23.59B | $21.85B | $20.86B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan